(Reuters) - Regulators on Thursday approved a once-monthly injectable form of Abilify, the blockbuster treatment for schizophrenia, which will be sold by Japanese drugmaker Otsuka and Danish drug group Lundbeck. In July 2012, the Food and Drug Administration declined to approve the medicine, Abilify Maintena, citing deficiencies from an inspection of a third-party supplier of sterile water. Otsuka and Lundbeck resubmitted their marketing application soon afterward, after working with an alternative supplier. ... via Health News Headlines - Yahoo! News CA Read More Here..
Lake forest health and fitness http://healthandfitness1blog.blogspot.com/2013/03/fda-approves-once-monthly-abilify-for.html
No comments:
Post a Comment